Genetic analysis tools for the research and diagnostic markets.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Element Biosciences is focused on innovating genetic analysis tools for the research and diagnostic markets.
Element Biosciences Funding
Sign up to gain insights into Element Biosciences funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Jun 28, 2024 | 267M | ||
| Series C | Jul 09, 2021 | 276M | ||
| Series B | Jun 26, 2020 | 30M | ||
| Series B | Apr 30, 2020 | 80M | ||
| Series A | Nov 26, 2018 | 15M | ||
| Series Seed | Oct 27, 2017 | 5M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Element Biosciences Management Team
Investors
RA Capital Management
Meritech Capital Partners
Wellington Management Company
T. Rowe Price
Foresite Capital
Foresight Ventures
Fidelity
JS Capital Management
Logos Capital
Venrock
Samsung
Janus Henderson
Alexandria Venture Investments
Counterpoint Global
Element Biosciences Valuations & Financials
View real-time NPM data on Element Biosciences stock including daily Element Biosciences stock price estimates, valuation history, and historical share price information. Access Element Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Element Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Element Biosciences? Get in touch to learn more.
Similar Companies
like Element Biosciences
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Ro
Healthcare & Life Sciences
Healthcare technology for a patient-centric healthcare system.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Kallyope
Healthcare & Life Sciences
Biotech company developing therapies targeting gut-brain axis interactions to treat metabolic and neurological diseases.
Owkin
Healthcare & Life Sciences
Biotechnology company using AI to personalize treatment.
FAQ
We have answers
Element Biosciences stock does not trade on public stock exchanges. Element Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Element Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Element Biosciences Stock does not trade on public stock exchanges. In order to sell Element Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Element Biosciences price per share was $7.36 as of July 22, 2026. This Element Biosciences share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Element Biosciences share price today and the factors driving Element Biosciences valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Element Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Element Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Element Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Element Biosciences is a private company and has not had an IPO. There is currently no Element Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Element Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
